|
AU2014274532A1
|
|
Dermal pharmaceutical compositions of 1-Methyl-2',6' pipecoloxylidide and method of use
|
|
US2014200237A1
|
|
Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14-diol
|
|
US2011097395A1
|
|
Oral Pharmaceutical Compositions of Buprenorphine and Method of Use
|
|
US2008280975A1
|
|
Methods of preventing the serotonin syndrome and compositions for use thereof
|
|
US2010249045A1
|
|
Multimodal abuse resistant and extended release opioid formulations
|
|
WO2008024408A2
|
|
Pharmaceutical formulations of cannabinoids for application to the skin and method of use
|
|
WO2008021394A2
|
|
Pharmaceutical formulations of cannabinoids and method of use
|
|
US2009082466A1
|
|
Abuse Resistant and Extended Release Formulations and Method of Use Thereof
|
|
US2010210732A1
|
|
Methods of Preventing the Serotonin Syndrome and Compositions for Use Therefor
|
|
WO2007005716A2
|
|
Methods of treatment and compositions for use thereof
|
|
WO2006116626A2
|
|
Methods and compositions for treating pain
|
|
WO2004091540A2
|
|
Methods of treating pain and compositions for use therefor
|
